Suggestion

Artmarket.com: Artprice comments launch of FrenchArtFund investment fund, regulated by the AMF

Retrieved on: 
Monday, February 5, 2024

A long-term investment in art produces and supports cultural and educational values that are different from traditional investments.

Key Points: 
  • A long-term investment in art produces and supports cultural and educational values that are different from traditional investments.
  • Investing in art is therefore not just an investment in a 'tangible' asset, it is also a fun and 'presentable' investment in our collective future."
  • Artprice: "Art is today widely considered as an alternative investment which not only offers high returns but also a low correlation to typical financial assets.
  • "I congratulate Olivier Bourdelas for the creation of the FrenchArtFund, the first Art Investment fund regulated by the AMF.

Ear seeds: what are they and why have they been controversially linked to ME without scientific evidence?

Retrieved on: 
Monday, February 5, 2024

Despite presenting no clinical evidence for the efficacy of Acu Seeds, Boxer made TV history by attracting offers of investment from all six of the Dragons.

Key Points: 
  • Despite presenting no clinical evidence for the efficacy of Acu Seeds, Boxer made TV history by attracting offers of investment from all six of the Dragons.
  • It’s little surprise, then, that her suggestion of a simple treatment such as ear seeds could help attracted such attention.
  • Ear seeds are used in a form of alternative therapy known as auricular therapy or ear acupressure.
  • However, robust scientific evidence supporting their therapeutic use does not exist.

No cure

  • Over half of patients are unable to work and a quarter of patients are bed- or housebound.
  • The exact disease mechanism is unknown, with research suggesting disturbances in the immune and nervous systems, the gut and energy production.
  • There is no cure for ME.
  • A serious under-investment in rigorous biomedical research into ME has meant that the illness remains somewhat of a mystery.
  • The absence of proven or effective treatments has created an environment allowing unproven treatment claims to thrive and potentially mislead vulnerable patients.
  • Addressing this gap in research funding is crucial for promoting scientific integrity and ensuring that treatments are grounded in robust scientific evidence.


Katharine Seton does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

AITX’s RAD Announces SelectBlur, a Privacy-First Surveillance Video Processing Application

Retrieved on: 
Thursday, February 1, 2024

Set for immediate release, SelectBlur represents RAD’s commitment to innovative, privacy-centric solutions in the security and surveillance industry.

Key Points: 
  • Set for immediate release, SelectBlur represents RAD’s commitment to innovative, privacy-centric solutions in the security and surveillance industry.
  • SelectBlur is a user-friendly application that allows clients to selectively blur faces in video footage, ensuring the privacy of individuals who are not the focus of the surveillance.
  • The application supports almost any video format and operates entirely on the desktop, eliminating the need for cloud-based processing and thereby further enhancing the security of sensitive data.
  • RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream.

ProSearch Advances eDiscovery with Generative AI for Review and Enhancements in Privacy Detection & Management

Retrieved on: 
Thursday, January 25, 2024

Both initiatives were developed by the ProSearch Linguistics, Analytics, and Data Science (LADS) team in collaboration with clients.

Key Points: 
  • Both initiatives were developed by the ProSearch Linguistics, Analytics, and Data Science (LADS) team in collaboration with clients.
  • Generative AI was harnessed to enhance efficiency, accuracy, and overall effectiveness in managing large volumes of data in review.
  • Categorization: AI allows review teams to explore data by category or topic, supporting review boundary identification or probing responsiveness, issuing codes, or identifying hot documents.
  • “The LADS team is on fire with practical applications of generative AI,” says Gina Taranto, director of applied sciences at ProSearch.

Everlaw Unveils New AI Features in its EverlawAI Portfolio, Driving Better Legal Outcomes

Retrieved on: 
Wednesday, January 24, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240124102471/en/
    With Coding Suggestions, a new generative AI feature in EverlawAI Assistant, legal teams can speed up the review of documents through automated coding suggestions.
  • (Graphic: Business Wire)
    Everlaw expects to release EverlawAI Assistant for general availability this year.
  • More than 40 customers comprising 1,100 legal professionals from law firms, corporations, and government agencies are using EverlawAI Assistant in a beta program launched in July 2023.
  • “With embedded GenAI, the Everlaw platform is helping legal teams navigate ediscovery, build their case and speed their time to resolution,” said AJ Shankar, founder and CEO, Everlaw.

Exploring the Social 4.0 Era: ZEGOCLOUD's Whitepaper on Interactive Innovations

Retrieved on: 
Monday, January 22, 2024

ZEGOCLOUD , a leading global cloud communication service provider, released its " Interactive Innovations: Social Entertainment in the Digital Age " whitepaper.

Key Points: 
  • ZEGOCLOUD , a leading global cloud communication service provider, released its " Interactive Innovations: Social Entertainment in the Digital Age " whitepaper.
  • This comprehensive report dives into the dynamics of the online social entertainment industry, unveiling new avenues for profitability in the emergent Social 4.0 era.
  • It dissects the evolution of social interaction, highlighting the transformative impact of technology on the way we connect and engage, especially post-pandemic.
  • It further examines the metamorphosis of social interaction methods, revealing how digital advancements are reshaping our communicative practices.

Hollywood's Portrayal of Cancer in Movies Fuels Misconceptions, New Study Finds

Retrieved on: 
Wednesday, January 17, 2024

NEWPORT BEACH, Calif., Jan. 17, 2024 /PRNewswire/ -- Hollywood films may provide an unrealistic view of cancer to individuals with cancer and their families, and can create misunderstandings about curability, treatment options, types of care available and cost, according to a study published today in JCO Oncology Practice. The study was led by David J. Benjamin, M.D., a medical oncologist at Hoag in Newport Beach, California.

Key Points: 
  • "We found that the portrayals of cancer treatment, prognosis and cost of care in movies significantly diverge from reality and therefore may have an impact on how patients approach cancer care," said Dr. Benjamin.
  • The study found that the portrayal of type of cancer does not accurately reflect the most common cancers that are diagnosed.
  • Only four of the 100 movies addressed financial costs, with one focusing on the financial stresses associated with cancer treatment.
  • "Oncologists should be aware of how cancer is depicted in movies to anticipate and address potential discrepancies between patients' potential views and the reality of cancer care," the authors wrote.

FTC Pauses CARS Rule Effective Date

Retrieved on: 
Friday, January 19, 2024

The Federal Trade Commission has issued an order postponing the effective date of the Combatting Auto Retail Scams (CARS) Rule while a legal challenge against the rule is pending.

Key Points: 
  • The Federal Trade Commission has issued an order postponing the effective date of the Combatting Auto Retail Scams (CARS) Rule while a legal challenge against the rule is pending.
  • Two industry groups have petitioned to overturn the rule, asserting that the rule should be stayed while the court challenge is pending.
  • The Commission further notes that if the court reviewing the rule grants expedited review, as the litigants requested, a stay of the effective date should not postpone implementation of the rule by more than a few months, if at all.
  • Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.

FTC Pauses CARS Rule Effective Date

Retrieved on: 
Friday, January 19, 2024

The Federal Trade Commission has issued an order postponing the effective date of the Combatting Auto Retail Scams (CARS) Rule while a legal challenge against the rule is pending.

Key Points: 
  • The Federal Trade Commission has issued an order postponing the effective date of the Combatting Auto Retail Scams (CARS) Rule while a legal challenge against the rule is pending.
  • Two industry groups have petitioned to overturn the rule, asserting that the rule should be stayed while the court challenge is pending.
  • The Commission further notes that if the court reviewing the rule grants expedited review, as the litigants requested, a stay of the effective date should not postpone implementation of the rule by more than a few months, if at all.
  • Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.

DocGo Provides Additional Information to Refute Misleading Short Seller “Report”

Retrieved on: 
Tuesday, January 16, 2024

As we previously advised our shareholders, this short seller mischaracterizes and misrepresents facts that are already known to the public, and uses unsubstantiated claims to intentionally present an overall picture of DocGo, our leadership and our business that is deliberately false, misleading and defamatory.

Key Points: 
  • As we previously advised our shareholders, this short seller mischaracterizes and misrepresents facts that are already known to the public, and uses unsubstantiated claims to intentionally present an overall picture of DocGo, our leadership and our business that is deliberately false, misleading and defamatory.
  • DocGo has a robust compliance department that reviews our billing claims for medical necessity and other billing compliance issues.
  • The Company engages independent third-party audit firms to audit our claims, and independent parties to perform compliance effectiveness reviews.
  • The North East Ambulance Trust is not a subsidiary of DocGo - it is a customer of DocGo.